• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病量表随时间变化的比较反应性。

Comparative responsiveness of Parkinson's disease scales to change over time.

作者信息

Schrag Anette, Spottke Annika, Quinn Niall Patrick, Dodel Richard

机构信息

Department of Clinical Neurosciences, Royal Free Hospital, University College, Rowland Hill Street, London, UK.

出版信息

Mov Disord. 2009 Apr 30;24(6):813-8. doi: 10.1002/mds.22438.

DOI:10.1002/mds.22438
PMID:19199355
Abstract

The objective of the study is to examine the comparative responsiveness of outcome measures to assess progression over time in Parkinson's disease (PD). One hundred twenty-eight patients participating in a clinic-based naturalistic study of PD were assessed with the Hoehn and Yahr, UPDRS, MMSE, PDQ-39, PDQL, EQ-5D, and BDI scales at baseline and at 1 year. In addition, 82 patients in a community-based study of patients with PD who had completed self-rated Schwab and England, PDQ-39, EQ-5D, and BDI scales at baseline, were sent the same questionnaires at 1 and 4 years. Responsiveness was assessed using t-tests, standardised effect size, and standardised response mean. In both samples, the Hr-QoL measures were less responsive to change over time than the impairment and disability scales (Hoehn and Yahr, UPDRS, Schwab and England scales). In addition, in the clinic-based sample, Hoehn and Yahr and UPDRS ADL scale ("on") were more responsive to progression over time than UPDRS motor part and ADL part ("off"). Hr-QoL measures are less responsive to change over time than measures of impairment and disability. Although this suggests that these measures are less accurate in detecting subtle changes, it may also indicate that the multifactorial subjective assessment of Hr-QoL adapts to changes over time. Global assessment of overall impairment and disability (which incorporates motor and nonmotor features of PD), however, appeared relatively responsive to change over time in patients in a naturalistic setting.

摘要

本研究的目的是检验评估帕金森病(PD)随时间进展的结局指标的相对反应性。对128名参与基于门诊的PD自然主义研究的患者在基线和1年时使用Hoehn和Yahr量表、统一帕金森病评定量表(UPDRS)、简易精神状态检查表(MMSE)、帕金森病问卷-39项(PDQ-39)、帕金森病生活质量量表(PDQL)、欧洲五维度健康量表(EQ-5D)和贝克抑郁量表(BDI)进行评估。此外,对82名参与基于社区的PD患者研究的患者在基线时完成了自我评定的施瓦布和英格兰量表、PDQ-39、EQ-5D和BDI量表,并在1年和4年时向他们发送相同的问卷。使用t检验、标准化效应量和标准化反应均值评估反应性。在两个样本中,健康相关生活质量(Hr-QoL)指标随时间变化的反应性低于损伤和残疾量表(Hoehn和Yahr量表、UPDRS量表、施瓦布和英格兰量表)。此外,在基于门诊的样本中,Hoehn和Yahr量表以及UPDRS日常生活活动量表(“开”期)随时间进展的反应性高于UPDRS运动部分和日常生活活动部分(“关”期)。Hr-QoL指标随时间变化的反应性低于损伤和残疾指标。虽然这表明这些指标在检测细微变化方面不太准确,但这也可能表明对Hr-QoL的多因素主观评估会随时间变化而适应。然而,在自然主义环境中,对整体损伤和残疾的总体评估(其中纳入了PD运动和非运动特征)似乎对随时间变化的反应相对较好。

相似文献

1
Comparative responsiveness of Parkinson's disease scales to change over time.帕金森病量表随时间变化的比较反应性。
Mov Disord. 2009 Apr 30;24(6):813-8. doi: 10.1002/mds.22438.
2
Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.精神症状及其他非运动症状对帕金森病患者残疾状况的影响。
J Am Geriatr Soc. 2004 May;52(5):784-8. doi: 10.1111/j.1532-5415.2004.52219.x.
3
Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study.在一项前瞻性纵向研究中评估帕金森病患者与健康相关的生活质量。
Parkinsonism Relat Disord. 2007 Mar;13(2):108-14. doi: 10.1016/j.parkreldis.2006.07.009. Epub 2006 Oct 19.
4
Longitudinal psychometric attributes, responsiveness, and importance of change: An approach using the SCOPA-Psychosocial questionnaire.纵向心理测量属性、反应性及变化的重要性:一种使用SCOPA-心理社会问卷的方法。
Mov Disord. 2008 Aug 15;23(11):1516-23. doi: 10.1002/mds.22202.
5
Progression of motor impairment and disability in Parkinson disease: a population-based study.帕金森病运动功能障碍和残疾的进展:一项基于人群的研究。
Neurology. 2005 Nov 8;65(9):1436-41. doi: 10.1212/01.wnl.0000183359.50822.f2.
6
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.帕金森病功能障碍和残疾评定量表的系统评价
Mov Disord. 2002 Sep;17(5):867-76. doi: 10.1002/mds.10248.
7
The clinically important difference on the unified Parkinson's disease rating scale.统一帕金森病评定量表上具有临床意义的差异。
Arch Neurol. 2010 Jan;67(1):64-70. doi: 10.1001/archneurol.2009.295.
8
Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: part II, construct and content validity.统一帕金森病评定量表3.0套件的计量属性:第二部分,结构效度和内容效度。
Mov Disord. 2006 Nov;21(11):1892-8. doi: 10.1002/mds.21071.
9
Determinants of disability and quality of life in mild to moderate Parkinson disease.轻度至中度帕金森病患者残疾及生活质量的决定因素
Neurology. 2008 Jun 3;70(23):2241-7. doi: 10.1212/01.wnl.0000313835.33830.80.
10
International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.帕金森病非运动症状量表心理测量属性的国际研究。
Neurology. 2009 Nov 10;73(19):1584-91. doi: 10.1212/WNL.0b013e3181c0d416.

引用本文的文献

1
Quality of life in patients with progressive supranuclear palsy: a review of literature and implications for practice.进行性核上性麻痹患者的生活质量:文献综述及实践启示
Front Neurol. 2024 Nov 20;15:1476488. doi: 10.3389/fneur.2024.1476488. eCollection 2024.
2
Health-related quality of life in Parkinson's disease: systematic review and meta-analysis of EuroQol (EQ-5D) utility scores.帕金森病患者的健康相关生活质量:EuroQol (EQ-5D) 效用评分的系统评价和荟萃分析。
Qual Life Res. 2024 Jul;33(7):1781-1793. doi: 10.1007/s11136-024-03646-8. Epub 2024 Apr 6.
3
The severity assessment of Parkinson's disease based on plasma inflammatory factors and third ventricle width by transcranial sonography.
基于经颅超声的血浆炎症因子和第三脑室宽度评估帕金森病的严重程度。
CNS Neurosci Ther. 2024 Mar;30(3):e14670. doi: 10.1111/cns.14670.
4
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression.帕金森进展标志物倡议:一种基于里程碑的策略,用于监测帕金森病的进展。
J Parkinsons Dis. 2023;13(6):899-916. doi: 10.3233/JPD-223433.
5
Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change.利用早期纵向变化模式对帕金森病进展进行预后建模。
Mov Disord. 2021 Dec;36(12):2853-2861. doi: 10.1002/mds.28730. Epub 2021 Jul 30.
6
Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson's Disease: A Swedish Register-Based Study in 1823 Observations.基于 Hoehn 和 Yahr 量表和帕金森病停用时程的患者健康状态效用:一项瑞典基于登记的 1823 例观察研究。
Pharmacoeconomics. 2021 Oct;39(10):1141-1149. doi: 10.1007/s40273-021-01056-z. Epub 2021 Jul 7.
7
Palliative Care Intervention Trials for Adults Living With Progressive Central Nervous System Diseases and Their Caregivers: A Systematic Review.成人进展性中枢神经系统疾病及其照护者的姑息治疗干预试验:系统评价。
J Pain Symptom Manage. 2022 Jan;63(1):e88-e110. doi: 10.1016/j.jpainsymman.2021.06.010. Epub 2021 Jun 18.
8
MRI-visible perivascular spaces are associated with cerebrospinal fluid biomarkers in Parkinson's disease.MRI 可见的血管周围间隙与帕金森病的脑脊液生物标志物相关。
Aging (Albany NY). 2020 Nov 25;12(24):25805-25818. doi: 10.18632/aging.104200.
9
Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.帕金森病认知和运动进展的全基因组关联研究。
Mov Disord. 2021 Feb;36(2):424-433. doi: 10.1002/mds.28342. Epub 2020 Oct 28.
10
Identification of distinct blood-based biomarkers in early stage of Parkinson's disease.在帕金森病早期阶段鉴定出不同的基于血液的生物标志物。
Neurol Sci. 2020 Apr;41(4):893-901. doi: 10.1007/s10072-019-04165-y. Epub 2019 Dec 11.